Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

The Company recognized stock-based compensation on all employee and non-employee awards as follows:

	For the Three Months Ended March 31, 2022		For the Three Months Ended March 31, 2021
Research and development	$	39,455	$	30,927
General and administrative		50,792		1,092,834
Total Stock-based compensation	$	90,247	$	1,123,761

The following table summarizes the stock option activity during the three months ended March 31, 2022:

Summary of Stock Option Activity

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value⁽¹⁾
Outstanding at December 31, 2021		6,724,402		$	0.95		7.99	$	2,773
Granted		—			—		—	$	—
Exercised		—			—		—	$	—
Forfeited		(54,498	)		1.53		—	$	—
Outstanding at March 31, 2022		6,669,904		$	0.95		7.75	$	—

Exercisable at March 31, 2022		5,961,568		$	0.96		7.61	$	—

(1)	The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2021 and March 31, 2022, respectively.